These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 25908693)

  • 1. Ateplase for ischaemic stroke: increased risk of intracranial haemorrhage is balanced by improved stroke outcomes, particularly if treated within 3-4.5 h of onset.
    Rudd A
    Evid Based Nurs; 2015 Oct; 18(4):116. PubMed ID: 25908693
    [No Abstract]   [Full Text] [Related]  

  • 2. Reperfusion trials for acute ischaemic stroke.
    Parsons MW; Levi CR
    Lancet; 2012 Aug; 380(9843):706-8. PubMed ID: 22748819
    [No Abstract]   [Full Text] [Related]  

  • 3. A multicentre, randomized, double-blinded, placebo-controlled Phase III study to investigate EXtending the time for Thrombolysis in Emergency Neurological Deficits (EXTEND).
    Ma H; Parsons MW; Christensen S; Campbell BC; Churilov L; Connelly A; Yan B; Bladin C; Phan T; Barber AP; Read S; Hankey GJ; Markus R; Wijeratne T; Grimley R; Mahant N; Kleinig T; Sturm J; Lee A; Blacker D; Gerraty R; Krause M; Desmond PM; McBride SJ; Carey L; Howells DW; Hsu CY; Davis SM; Donnan GA;
    Int J Stroke; 2012 Jan; 7(1):74-80. PubMed ID: 22188854
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ischaemic stroke: decide rapidly.
    Prescrire Int; 2015 Sep; 24(163):221. PubMed ID: 26417638
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alteplase in acute ischaemic stroke: the need for speed.
    Hill MD; Coutts SB
    Lancet; 2014 Nov; 384(9958):1904-6. PubMed ID: 25106064
    [No Abstract]   [Full Text] [Related]  

  • 6. Earlier thrombolytic treatment is associated with better outcomes following acute ischaemic stroke.
    Ullah N; Thompson MJ; Qureshi AI
    Evid Based Nurs; 2014 Oct; 17(4):107. PubMed ID: 24504528
    [No Abstract]   [Full Text] [Related]  

  • 7. Thrombolysis in acute ischaemic stroke.
    Smith B
    Lancet; 2012 Sep; 380(9847):1053; author reply 1054-5. PubMed ID: 22998704
    [No Abstract]   [Full Text] [Related]  

  • 8. Thrombolysis in acute ischaemic stroke.
    Newman DH; Shreves AE
    Lancet; 2012 Sep; 380(9847):1053-4; author reply 1054-5. PubMed ID: 22998705
    [No Abstract]   [Full Text] [Related]  

  • 9. Thrombolysis in acute ischaemic stroke.
    Fatovich DM; MacDonald SP; Brown SG
    Lancet; 2012 Sep; 380(9847):1053; author reply 1054-5. PubMed ID: 22998706
    [No Abstract]   [Full Text] [Related]  

  • 10. Thrombolysis in acute ischaemic stroke.
    Curtis D
    Lancet; 2012 Sep; 380(9847):1054; author reply 1054-5. PubMed ID: 22998707
    [No Abstract]   [Full Text] [Related]  

  • 11. Thrombolysis in acute ischaemic stroke.
    Barer D
    Lancet; 2012 Sep; 380(9847):1054; author reply 1054-5. PubMed ID: 22998709
    [No Abstract]   [Full Text] [Related]  

  • 12. Timing of thrombolysis for acute ischaemic stroke: the earlier the treatment the better the outcome, irrespective of age or stroke severity.
    Lorenzano S
    Evid Based Med; 2015 Jun; 20(3):108. PubMed ID: 25854628
    [No Abstract]   [Full Text] [Related]  

  • 13. Statin use and functional outcome after tissue plasminogen activator treatment in acute ischaemic stroke.
    Miedema I; Uyttenboogaart M; Koopman K; De Keyser J; Luijckx GJ
    Cerebrovasc Dis; 2010 Feb; 29(3):263-7. PubMed ID: 20090317
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intravenous recombinant tissue plasminogen activator administered after 3 h following onset of ischaemic stroke: a metaanalysis.
    Maiser SJ; Georgiadis AL; Suri MF; Vazquez G; Lakshminarayan K; Qureshi AI
    Int J Stroke; 2011 Feb; 6(1):25-32. PubMed ID: 21205237
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Influence of antiplatelet pre-treatment on the risk of intracranial haemorrhage in acute ischaemic stroke after intravenous thrombolysis.
    Dorado L; Millán M; de la Ossa NP; Guerrero C; Gomis M; López-Cancio E; Ricciardi AC; Dávalos A
    Eur J Neurol; 2010 Feb; 17(2):301-6. PubMed ID: 19912320
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Timeframe for thrombolysis in acute ischaemic stroke.
    Tsivgoulis G; Alexandrov AV
    Lancet; 2008 Oct; 372(9646):1275-6. PubMed ID: 18790526
    [No Abstract]   [Full Text] [Related]  

  • 17. Routine thrombolysis with intravenous tissue plasminogen activator in acute ischaemic stroke patients aged 80 years or older: a single centre experience.
    Uyttenboogaart M; Schrijvers EM; Vroomen PC; De Keyser J; Luijckx GJ
    Age Ageing; 2007 Sep; 36(5):577-9. PubMed ID: 17405776
    [No Abstract]   [Full Text] [Related]  

  • 18. Estimated weight is not a reliable measure for dosing tissue plasminogen activator for thrombolysis in acute ischaemic stroke.
    Gill D; Halsey L; Kalkat H; Patel S; Kar A
    Int J Stroke; 2016 Feb; 11(2):NP25-6. PubMed ID: 26783320
    [No Abstract]   [Full Text] [Related]  

  • 19. rt-PA for ischaemic stroke: what will the next question be?
    Leys D; Cordonnier C
    Lancet; 2012 Jun; 379(9834):2320-1. PubMed ID: 22632906
    [No Abstract]   [Full Text] [Related]  

  • 20. Reperfusion and outcomes in Penumbra vs. systemic tissue plasminogen activator clinical trials.
    Alexandrov AV; Schellinger PD; Saqqur M; Barreto A; Demchuk AM; Ribo M; Rubiera M; Sharma VK; Heliopoulos I; Alexandrov AW; Molina CA; Tsivgoulis G;
    Int J Stroke; 2011 Apr; 6(2):118-22. PubMed ID: 21371272
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.